A trial of Gilead’s coronavirus drug has been slowed, as eligible recruits prove hard to come by https://t.co/rX162cgpAJ
— The Wall Street Journal (@WSJ) February 18, 2020
Source: Twitter
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.